About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
+13 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Technicals
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Deliverable Volumes
Glenmark Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:
532296
NSE Symbol:
GLENMARK
P/E :
35.29
ISIN Demat:
INE935A01035
Div & Yield %:
0.11
EPS :
61.81
Book Value:
868.32
Market Cap (Rs. Cr.):
61,563.52
Face Value :
1
Exchange
BSE
NSE
Period From
Period To
Date
Quantity Traded
Quantity Delivered
Change %
27 Jun 2025
8989
2309
25.69
30 Jun 2025
17802
6849
38.47
01 Jul 2025
6294
1697
26.96
02 Jul 2025
16247
6647
40.91
03 Jul 2025
10699
4861
45.43
04 Jul 2025
18902
8223
43.50
07 Jul 2025
39640
14864
37.50
08 Jul 2025
22703
9304
40.98
09 Jul 2025
27901
19875
71.23
10 Jul 2025
96575
25014
25.90